The presence of minute amounts of chelators can help minimize the degradation of monoclonal antibodies.
Sangita Chandrasekharan
Advertisement
Sangita Chandrasekharan is global liaison senior manager, novartis, Building no. 6, Mind Space, Hitech City, Hyderabad, Andhra Pradesh 500081, India.
Articles by Sangita Chandrasekharan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
2
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
3
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
4
Estuary Biotherapeutics Launches With $103 Million for ADPKD Gene Therapy
5